333 related articles for article (PubMed ID: 15998941)
21. Overall survival in metastatic breast cancer: always our quest but not necessarily a primary endpoint.
Robert NJ
Breast Cancer Res Treat; 2010 Jul; 122(1):9-10. PubMed ID: 20495865
[No Abstract] [Full Text] [Related]
22. Bevacizumab: current updates in treatment.
Van Meter ME; Kim ES
Curr Opin Oncol; 2010 Nov; 22(6):586-91. PubMed ID: 20811277
[TBL] [Abstract][Full Text] [Related]
23. New drugs for ovarian cancer.
Kaye SB
Clin Adv Hematol Oncol; 2008 Feb; 6(2):91-3. PubMed ID: 18347558
[No Abstract] [Full Text] [Related]
24. Bevacizumab treatment for solid tumors: boon or bust?
Hayes DF
JAMA; 2011 Feb; 305(5):506-8. PubMed ID: 21285431
[No Abstract] [Full Text] [Related]
25. [Anti-angiogenic factors in thoracic oncology: successes, failures and prospects].
Marco S; Tomasini P; Greillier L; Barlesi F
Rev Mal Respir; 2011 Dec; 28(10):1216-29. PubMed ID: 22152931
[TBL] [Abstract][Full Text] [Related]
26. Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: pros and cons.
Sini V; Cassano A; Corsi D; De Laurentiis M; Gamucci T; Mauri M; Naso G; Roselli M; Ruggeri EM; Tonini G; Vici P; Zampa G; Marchetti P
Tumori; 2016 Oct; 102(5):472-480. PubMed ID: 27647231
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy: what progress in the last 5 years?
Hamilton A; Hortobagyi G
J Clin Oncol; 2005 Mar; 23(8):1760-75. PubMed ID: 15755984
[No Abstract] [Full Text] [Related]
28. Osteonecrosis of the jaw and bevacizumab therapy.
Van Poznak C
Breast Cancer Res Treat; 2010 Jul; 122(1):189-91. PubMed ID: 20464477
[No Abstract] [Full Text] [Related]
29. Accrual delayed in adjuvant bevacizumab trial.
Tuma RS
J Natl Cancer Inst; 2006 Apr; 98(7):439-40. PubMed ID: 16595779
[No Abstract] [Full Text] [Related]
30. 10 Questions about the use of bevacizumab in the management of recurrent malignant gliomas.
Chamberlain MC
Neurologist; 2010 Jan; 16(1):56-60. PubMed ID: 20065801
[No Abstract] [Full Text] [Related]
31. [Metastatic breast cancer--new methods of treatment].
Rack B; Heinemann V; Schindlbeck C; Walther J; Salat C; Sommer H
MMW Fortschr Med; 2008 Jan; 150(1-2):34-6. PubMed ID: 18300641
[No Abstract] [Full Text] [Related]
32. Bevacizumab and breast cancer: the E2100 outlier.
Fojo T; Wilkerson J
Lancet Oncol; 2010 Dec; 11(12):1117-9. PubMed ID: 21126685
[No Abstract] [Full Text] [Related]
33. Bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer: an evidence-based approach.
Tassinari D; Sartori S; Papi M; Drudi F; Castellani C; Carloni F; Tombesi P; Lazzari-Agli L
Oncology; 2011; 80(5-6):350-8. PubMed ID: 21791945
[TBL] [Abstract][Full Text] [Related]
34. Experience with bevacizumab in the management of epithelial ovarian cancer.
Burger RA
J Clin Oncol; 2007 Jul; 25(20):2902-8. PubMed ID: 17617521
[TBL] [Abstract][Full Text] [Related]
35. Bevacizumab in the treatment of metastatic colorectal cancer.
Caprioni F; Fornarini G
Future Oncol; 2007 Apr; 3(2):141-8. PubMed ID: 17381413
[TBL] [Abstract][Full Text] [Related]
36. The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab.
Marty M; Pivot X
Eur J Cancer; 2008 May; 44(7):912-20. PubMed ID: 18396037
[TBL] [Abstract][Full Text] [Related]
37. Antiangiogenesis research is booming, as questions and studies proliferate.
Brower V
J Natl Cancer Inst; 2009 Jun; 101(11):780-1. PubMed ID: 19470957
[No Abstract] [Full Text] [Related]
38. Bevacizumab and recurrent malignant gliomas: a European perspective.
Wick W; Weller M; van den Bent M; Stupp R
J Clin Oncol; 2010 Apr; 28(12):e188-9; author reply e190-2. PubMed ID: 20159801
[No Abstract] [Full Text] [Related]
39. Avastin withdrawal symptoms.
Lynce F; Swain SM
Expert Opin Pharmacother; 2012 Feb; 13(3):293-8. PubMed ID: 22263961
[No Abstract] [Full Text] [Related]
40. [Metastatic colorectal carcinoma: bevacizumab extends total survival].
Pflege Z; 2013 Apr; 66(4):252. PubMed ID: 23634556
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
